Dr. Sepesi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
499 E Hampden Ave
Ste 200
Englewood, CO 80113Phone+1 303-409-1430Fax+1 303-781-2218
Education & Training
University of Texas MD Anderson Cancer Center/University of Texas Medical School at HoustonFellowship, Thoracic Surgery, 2011 - 2013
University of RochesterResidency, Surgery, 2005 - 2011
University of ColoradoResidency, Internal Medicine, 2004 - 2004
Jagiellonian University Medical CollegeClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2013 - 2026
CO State Medical License 2023 - 2025
OK State Medical License 2020 - 2021
NY State Medical License 2008 - 2013- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma Start of enrollment: 2019 Oct 02
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 358 citationsNeoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.Tina Cascone, William N. William, Annikka Weissferdt, Cheuk Hong Leung, Heather Lin
Nature Medicine. 2021-02-18 - 24 citationsEvaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.Apar Pataer, Annikka Weissferdt, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi
Journal of Thoracic Oncology. 2021-04-20 - 19 citationsPredictors of survival following surgical resection of limited-stage small cell lung cancerNicolas Zhou, Matthew J. Bott, Bernard J. Park, Eric Vallières, Candice L. Wilshire
The Journal of Thoracic and Cardiovascular Surgery. 2021-03-01
Authored Content
- My Top 5 Most Practice-Changing Presentations at WCLCOctober 2018
Press Mentions
Foundation Medicine Partners with Lung Cancer Research Foundation and the Lung Cancer Mutation Consortium on Screening Trial to Enable Precision TherapyJune 3rd, 2022- Circulating Cellular Determinants to Predict Response to Anti-PD-1 Monotherapy in Patients with Malignant Pleural MesotheliomaMay 15th, 2022
- Adding Atezolizumab to Neoadjuvant Cisplatin-Pemetrexed a Feasible Option in Malignant Pleural MesotheliomaOctober 15th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
